HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Physicians Formula Highlights Clinical Data Behind First National Skin-Care Line

This article was originally published in The Rose Sheet

Executive Summary

As it enters the crowded skin-care market, Physicians Formula is counting on clinical trial results and efficacious ingredients highlighted on product packaging to distinguish its line from the competition.

You may also be interested in...



Physicians Formula Bought For $65 Mil. By Private Equity

Swander Pace Capital pads its personal care portfolio with the acquisition of skin care and color cosmetics brand Physicians Formula.

In Brief

People In Brief

Jill Beraud, former executive VP of marketing for Limited Brands divisions including Bath & Body Works and C.O. Bigelow, takes the helm at Living Proof. Meanwhile, Physicians Formula and International Flavors & Fragrances are searching for a new CFO and supply chain head, respectively.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017761

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel